Proof — Case Study

Bausch + Lomb
83 studies. 35 new claims. Three weeks.

Science Intelligence™

A new product for an underserved consumer health need — and a launch team that needed to know exactly what could be said about it, compliantly, before committing to the formula.

The Story

Bausch + Lomb had gathered a strong, well-organized body of clinical literature across the formulation's ingredients — what it didn't yet have was a claims layer: that evidence graded and tied directly to compliant claim language. The requirement: structure-function claims that trace directly back to source studies and survive medical, legal, and regulatory review. The audience: healthcare professionals — skeptical readers who check the references.

Our Claim Dev™ engine organized the full evidence base into a graded, searchable claims library, developed compliant structure-function claims tied to source studies, and re-verified every claim-supporting study against the published record — authors, N, endpoints.

The claims were approved by Bausch + Lomb's medical, legal, and regulatory teams in three weeks — informed by two specialist advisory boards. A complete, MLR-approved claims roadmap, delivered while the product was still being formulated.

Product and category details confidential by agreement.

  • Claim Dev™
  • Graded claims library
  • Source-log verification
  • HCP narrative themes
Results
83 clinical studies
Analyzed into a graded, searchable claims library
35 new compliant claims
Structure-function, tied to source studies, evidence-graded
5 HCP narrative themes
Plus 3 hero claim concepts and 6 patient profiles
MLR approved
In three weeks, while the product was still in formulation

More work

Case StudyCheers Health — MOAScience, share-worthy.View →Case StudyCheers HealthThree weeks, not six months.View →Case StudyDesigns for HealthNot all vitamin D is equal.View →Case StudyEmerson Logistics1 order. 1 truck. 1 payment.View →Case StudyFlonaseOne dose. Six allergens.View →Case StudyHealthCareAislePrivate label, public proof.View →Case StudyiVIZIAWe see a better way.View →Case StudyLotriminAthlete's foot loves a comeback.View →Case StudyMetrum Research GroupComplexity, distilled.View →Case StudyNexium 24HRBold claims win.View →Case StudyQunol10x better absorption.View →Case StudyVera TherapeuticsClinical data, communicated.View →

Want results like these?

Every one of them started with the science.

Start a Project